Denis Kay

Gründer bei ALPHA COGNITION INC.

Consumer Services

Health Technology

Finance

Profil

Denis G.
Kay is the founder of Alpha Cognition, Inc., founded in 2000, serving as Chief Scientific Officer.
Dr. Kay is the founder of Neurodyn Life Sciences, Inc., founded in 2006, serving as Chief Scientific Officer.
Former job includes Director & Chief Scientific Officer at Neurodyn, Inc. Education includes a doctorate from McGill University and undergraduate and graduate degrees from Dalhousie University.

Aktive Positionen von Denis Kay

Unternehmen	Position	Beginn
ALPHA COGNITION INC.	Gründer	01.01.2000
Neurodyn Life Sciences, Inc. Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases	Gründer	01.08.2006

Alle aktiven Positionen von Denis Kay

Ehemalige bekannte Positionen von Denis Kay

Unternehmen	Position	Ende
Neurodyn, Inc. Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Denis Kay im Detail an

Ausbildung von Denis Kay

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Denis Kay im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
McGill University McGill University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dalhousie University Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neurodyn, Inc. Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection	Health Technology
Neurodyn Life Sciences, Inc. Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases	Health Technology
Alpha Cognition, Inc. Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases	Finance